Arvaya Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please take note that the Meeting of the Board of Directors of the Company is scheduled to be held on Friday, November 13, 2026, to consider and approve, inter-alia, ....

Date: 08.11.2026 The Secretary, Listing Department BSE Limited Phiroze Jeejeebhoy Towers, Street, Mumbai – 400 001 Sub.: Board Meeting intimation under Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Scrip Code: 524723 ISIN: INE491D01017 Respected Authorities, Pursuant to the provisions of Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please take note that the Meeting of the Board of Directors of the Company is scheduled to be held on Friday, November 13, 2026, to consider and approve, inter-alia, the Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Half Year ended September 30, 2026. Pursuant to the Company’s Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in Company’s Securities is already closed from Thursday, October 01, 2026, for all Designated Employees of the Company and will open 48 hours after the aforesaid Financial Results are declared to the Stock Exchange. Kindly take the above on record. Thanking you, Yours faithfully, For Arvaya Healthcare Limited (formerly known as Bijoy Hans Limited) Kaushal Shah Managing Director DIN: 02175130